致力于药物研发关键试剂的生产

15801534258
info@nebulabio.cn
产品名称 NebuSelect™ Recombinant Cynomolgus LILRA4/CD85g, His-tag
目录号 NBL-240846
别名 LILRA4/CD85g; CD85g; ILT7; ILT-7; ILT7MGC129598; LILRA4; MGC129597
外观 see COA
分子量 Glu24-Asn446
CAS N/A
溶解度 Water Soluble
存储条件 Short term 4℃; Long term -20℃.
保存时间 2 years
备注1 XP_005590346.1
备注2
目录号 规格 价格 库存状态  
NBL-240846-100ug 100ug Inquire Inquire
NBL-240846-1mg 1mg Inquire Inquire
NBL-240846-Customized Size N/A Inquire Inquire


Product Name:

NebuSelect™ Recombinant Cynomolgus LILRA4/CD85g, His-tag


Catalog#:

NBL-240846


Description:

NebuSelect™ Recombinant Cynomolgus LILRA4/CD85g, His-tag(Cat#NBL-240846) is expressed in HEK293 with His tag at the C-Terminus.It contains Glu24-Asn446.


Species:

Cynomolgus


Expression System:

HEK293


Molecular Weight: 

The protein has a predicted MW of 47.7 kDa. Due to glycosylation, the protein migrates to 58-68 kDa based on Bis-Tris PAGE result.


Target Name:

LILRA4/CD85g; CD85g; ILT7; ILT-7; ILT7MGC129598; LILRA4; MGC129597


Target Information:

LILRA4, also known as ILT7 and CD85g, is an approximately 60-70 kDa variably glycosylated transmembrane protein that regulates immune cell activation. Mature human LILRA4 consists of a 423 amino acid (aa) extracellular domain (ECD) with four immunoglobulin-like domains, a 21 aa transmembrane segment, and a 32 aa cytoplasmic domain.LILRA4 function coreceptor to limit the innate immune responses to viral infections; signaling occurs via FCER1G (PubMed:16735691, PubMed:19564354). Down-regulates the production of IFNA1, IFNA2, IFNA4, IFNB1 and TNF by plasmacytoid dendritic cells that have been exposed to influenza virus or cytidine-phosphate-guanosine (CpG) dinucleotides, indicating it functions as negative regulator of TLR7 and TLR9 signaling cascades.


Amino Acid Sequence: 

Glu24-Asn446


Purity:

>95%


Formulation:

see COA


Endotoxin:

<1EU/ug(LAL Method)


Storage: 

4°C for short term. 

-20°C for long term.


To get more information, please contact us freely.

相关产品